Cell Therapies in Sarcomas: Lete-cel in Synovial Sarcoma & MRCLs

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this episode of OncoDaily, Dr. Sandra D'Angelo, a renowned sarcoma expert from Memorial Sloan Kettering Cancer Center, joins Amalya Sargsyan to discuss the IGNYTE-ESO trial. This pioneering study highlights Lete-cel, an adoptive T-cell therapy showing a 42% response rate in synovial sarcoma and myxoid round cell liposarcoma (MRCLS). Dr. D'Angelo delves into key findings, including response durability, safety profiles, and the transformative potential of cell therapies in sarcoma care.

Tune in for expert insights into the future of sarcoma treatment!
@mskcc

#Cancer #Oncology #OncoDaily #SarcomaTreatment #MSKCC #LeteCel #CellTherapy #MRCLS #SynovialSarcoma #CancerResearch #AdoptiveTCellTherapy #SarcomaCare #CancerInnovation #FutureOfOncology #SarcomaExperts

00:00 Introduction
01:11 IGNYTE-ESO Trial: Overview and Clinical Context
05:24 New Hope for Sarcoma Patients
08:23 Safety and Side Effects of Lete-cel
11:08 Exploring Cell Therapy and Lete-Cel
14:17 Future of Cell Therapies in Sarcomas: Promise and Progress

SUBSCRIBE to get the latest #oncodaily https://www.youtube.com/@OncoDailyTV

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn: https://linkedin.com/company/oncodaily
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram: https://www.instagram.com/oncodailynews/
Follow OncoDaily on TikTok: https://www.tiktok.com/@oncodaily
Like OncoDaily on Facebook: https://www.facebook.com/oncodaily/

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
Category
Oncology
Be the first to comment

Up Next